Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis
- Issued Date
- 2020
- Type
- Article
- Publisher
- THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
- Language
- 영어
- ISSN
- 1758-8340
- Citation Volume
- 12
- Citation Number
- 0
- Citation Start Page
- 0
- Citation End Page
- 0
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.